Squamous cell carcinoma keratinocytes isolated from patients with recessive dystrophic epidermolysis bullosa do not differ in expression of p53, p16, activated H-ras, c-myc, phosphorylated STAT3 and phosphorylated AKT or in their response to transforming growth factor-beta, tumour necrosis factor-alpha or NF-kappa B inhibition when compared with ultraviolet-induced squamous cell carcinoma keratinocytes

C. Hogan; C. Pourreyron; K. Purdie; C. L. Cole; L. Bruckner-Tuderman; C. Proby; J. A. McGrath; I. M.  Leigh; A. P.  South

doi:10.1111/j.1365-2133.2009.09092.x

Squamous cell carcinoma keratinocytes isolated from patients with recessive dystrophic epidermolysis bullosa do not differ in expression of p53, p16, activated H-ras, c-myc, phosphorylated STAT3 and phosphorylated AKT or in their response to transforming growth factor-beta, tumour necrosis factor-alpha or NF-kappa B inhibition when compared with ultraviolet-induced squamous cell carcinoma keratinocytes

C. Hogan, C. Pourreyron, K. Purdie, C. L. Cole, L. Bruckner-Tuderman, C. Proby, J. A. McGrath, I. M. Leigh, A. P. South

Research output: Contribution to journal › Book/Film/Article review › peer-review

Original language	English
Pages (from-to)	925-925
Number of pages	1
Journal	British Journal of Dermatology
Volume	160
Issue number	4
DOIs	https://doi.org/10.1111/j.1365-2133.2009.09092.x
Publication status	Published - Apr 2009

Access to Document

10.1111/j.1365-2133.2009.09092.x

Cite this

Hogan, C., Pourreyron, C., Purdie, K., Cole, C. L., Bruckner-Tuderman, L., Proby, C., McGrath, J. A., Leigh, I. M., & South, A. P. (2009). Squamous cell carcinoma keratinocytes isolated from patients with recessive dystrophic epidermolysis bullosa do not differ in expression of p53, p16, activated H-ras, c-myc, phosphorylated STAT3 and phosphorylated AKT or in their response to transforming growth factor-beta, tumour necrosis factor-alpha or NF-kappa B inhibition when compared with ultraviolet-induced squamous cell carcinoma keratinocytes. British Journal of Dermatology, 160(4), 925-925. https://doi.org/10.1111/j.1365-2133.2009.09092.x

Hogan, C. ; Pourreyron, C. ; Purdie, K. et al. / Squamous cell carcinoma keratinocytes isolated from patients with recessive dystrophic epidermolysis bullosa do not differ in expression of p53, p16, activated H-ras, c-myc, phosphorylated STAT3 and phosphorylated AKT or in their response to transforming growth factor-beta, tumour necrosis factor-alpha or NF-kappa B inhibition when compared with ultraviolet-induced squamous cell carcinoma keratinocytes. In: British Journal of Dermatology. 2009 ; Vol. 160, No. 4. pp. 925-925.

@article{bab7497359734091a4cd594d76737302,

title = "Squamous cell carcinoma keratinocytes isolated from patients with recessive dystrophic epidermolysis bullosa do not differ in expression of p53, p16, activated H-ras, c-myc, phosphorylated STAT3 and phosphorylated AKT or in their response to transforming growth factor-beta, tumour necrosis factor-alpha or NF-kappa B inhibition when compared with ultraviolet-induced squamous cell carcinoma keratinocytes",

author = "C. Hogan and C. Pourreyron and K. Purdie and Cole, \{C. L.\} and L. Bruckner-Tuderman and C. Proby and McGrath, \{J. A.\} and Leigh, \{I. M.\} and South, \{A. P.\}",

year = "2009",

month = apr,

doi = "10.1111/j.1365-2133.2009.09092.x",

language = "English",

volume = "160",

pages = "925--925",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "4",

}

Hogan, C, Pourreyron, C, Purdie, K, Cole, CL, Bruckner-Tuderman, L, Proby, C, McGrath, JA, Leigh, IM & South, AP 2009, 'Squamous cell carcinoma keratinocytes isolated from patients with recessive dystrophic epidermolysis bullosa do not differ in expression of p53, p16, activated H-ras, c-myc, phosphorylated STAT3 and phosphorylated AKT or in their response to transforming growth factor-beta, tumour necrosis factor-alpha or NF-kappa B inhibition when compared with ultraviolet-induced squamous cell carcinoma keratinocytes', British Journal of Dermatology, vol. 160, no. 4, pp. 925-925. https://doi.org/10.1111/j.1365-2133.2009.09092.x

Squamous cell carcinoma keratinocytes isolated from patients with recessive dystrophic epidermolysis bullosa do not differ in expression of p53, p16, activated H-ras, c-myc, phosphorylated STAT3 and phosphorylated AKT or in their response to transforming growth factor-beta, tumour necrosis factor-alpha or NF-kappa B inhibition when compared with ultraviolet-induced squamous cell carcinoma keratinocytes. / Hogan, C.; Pourreyron, C.; Purdie, K. et al.
In: British Journal of Dermatology, Vol. 160, No. 4, 04.2009, p. 925-925.

Research output: Contribution to journal › Book/Film/Article review › peer-review

TY - JOUR

T1 - Squamous cell carcinoma keratinocytes isolated from patients with recessive dystrophic epidermolysis bullosa do not differ in expression of p53, p16, activated H-ras, c-myc, phosphorylated STAT3 and phosphorylated AKT or in their response to transforming growth factor-beta, tumour necrosis factor-alpha or NF-kappa B inhibition when compared with ultraviolet-induced squamous cell carcinoma keratinocytes

AU - Hogan, C.

AU - Pourreyron, C.

AU - Purdie, K.

AU - Cole, C. L.

AU - Bruckner-Tuderman, L.

AU - Proby, C.

AU - McGrath, J. A.

AU - Leigh, I. M.

AU - South, A. P.

PY - 2009/4

Y1 - 2009/4

U2 - 10.1111/j.1365-2133.2009.09092.x

DO - 10.1111/j.1365-2133.2009.09092.x

M3 - Book/Film/Article review

SN - 0007-0963

VL - 160

SP - 925

EP - 925

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 4

ER -

Hogan C, Pourreyron C, Purdie K, Cole CL, Bruckner-Tuderman L, Proby C et al. Squamous cell carcinoma keratinocytes isolated from patients with recessive dystrophic epidermolysis bullosa do not differ in expression of p53, p16, activated H-ras, c-myc, phosphorylated STAT3 and phosphorylated AKT or in their response to transforming growth factor-beta, tumour necrosis factor-alpha or NF-kappa B inhibition when compared with ultraviolet-induced squamous cell carcinoma keratinocytes. British Journal of Dermatology. 2009 Apr;160(4):925-925. doi: 10.1111/j.1365-2133.2009.09092.x